Boehringer Ingelheim GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Boehringer Ingelheim GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7406
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company’s products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Boehringer Ingelheim GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Boehringer Ingelheim GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Boehringer Ingelheim GmbH, Medical Equipment, Deal Details 10
Partnerships 10
ImaginAb Enters into Agreement with Boehringer Ingelheim 10
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 11
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 12
BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim 13
Boehringer Ingelheim GmbH – Key Competitors 14
Boehringer Ingelheim GmbH – Key Employees 15
Boehringer Ingelheim GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Strategy And Business Planning 18
May 16, 2017: Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China 18
Financial Announcements 19
Aug 01, 2018: Boehringer Ingelheim achieves modest growth in the first half of 2018 19
Aug 02, 2017: Boehringer Ingelheim Achieves Good Growth in the First Half of 2017 20
Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 21
Corporate Communications 22
Jan 31, 2018: Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President & CEO Effective March 1, 2018. 22
Dec 15, 2017: Change in the Board of Managing Directors at Boehringer Ingelheim 23
Other Significant Developments 24
Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year 24
Feb 12, 2018: Boehringer Ingelheim Demonstrates their Commitment to Site Relationships by Joining SCRS’ Global Impact Partner Program 25
Sep 25, 2017: Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes 26
Jun 08, 2017: Boehringer Ingelheim builds Digital Lab “BI X” with focus on innovative digital solutions in healthcare 27
Mar 02, 2017: Boehringer Ingelheim sponsors the new building of the Research Institute of Molecular Pathology in Vienna with EUR 52 million 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Boehringer Ingelheim GmbH, Medical Equipment, Key Facts, 2016 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Boehringer Ingelheim GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Boehringer Ingelheim GmbH, Deals By Market, 2012 to YTD 2018 8
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ImaginAb Enters into Agreement with Boehringer Ingelheim 10
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 11
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 12
BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim 13
Boehringer Ingelheim GmbH, Key Competitors 14
Boehringer Ingelheim GmbH, Key Employees 15
Boehringer Ingelheim GmbH, Other Locations 16
Boehringer Ingelheim GmbH, Subsidiaries 16

List of Figures
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Boehringer Ingelheim GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Belk Inc:戦略・SWOT・企業財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Chongqing Taiji Industry (Group) Co Ltd (600129):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Taiji Industry (Group) Co Ltd (Chongqing Taiji) is a provider of generic products. The company offers products such as traditional Chinese medicine, hospital products, OTC products, base products, and dietary supplement. It provides research and development, equipment, and manageme …
  • Align Technology, Inc. (ALGN)-医療機器分野:企業M&A・提携分析
    Summary Align Technology, Inc. (Align) is a medical device company that designs, manufactures and markets orthodontics and services for orthodontic and restorative dentistry. The company’s portfolio encompasses a system of clear aligner therapy, intra-oral scanners, and computer-aided design, and co …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma Group) is a drug company that manufactures, develops, discovers, and commercializes novel formulations, natural drugs, medicinal products, pharmaceutical products, and biotechnology products. The group’s products include paclitaxel liposome, lentinan, sodiu …
  • EmCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EmCare Inc (EmCare) is a healthcare service provider that offers emergency department outsourcing services for the hospitals. The center provides emergency medicine, hospital medicine, acute care surgery, anesthesiology and radiology services. It provides recruitment, staffing, management, m …
  • Valero Energy Corp (VLO):石油・ガス:M&Aディール及び事業提携情報
    Summary Valero Energy Corp (Valero) is a downstream company that manufactures and markets transportation fuels and petrochemical products. The company’s assets include petroleum refineries, ethanol plants and renewable diesel production from a joint venture. Its refineries produce gasoline, diesel, …
  • Nucor Corp:企業の戦略・SWOT・財務情報
    Nucor Corp - Strategy, SWOT and Corporate Finance Report Summary Nucor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Botswana Power Corporation-エネルギー分野:企業M&A・提携分析
    Summary Botswana Power Corporation (BPC) is a parastatal utility that generates, transmits and distributes electricity. Its transmission network connects various towns in Botswana such as Maun, Shakawe, Gumare, Ghanzi, Pandamatenga and Kasane. BPC distributes electricity to areas approved by the Min …
  • Warimpex Finanz- und Beteiligungs AG:企業の戦略・SWOT・財務情報
    Warimpex Finanz- und Beteiligungs AG - Strategy, SWOT and Corporate Finance Report Summary Warimpex Finanz- und Beteiligungs AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Prologis, Inc.:戦略・SWOT・企業財務分析
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Philippine National Bank:企業の戦略・SWOT・財務分析
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Crane Co.:企業の戦略・SWOT・財務情報
    Crane Co. - Strategy, SWOT and Corporate Finance Report Summary Crane Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • U.P. Hotels Ltd.:企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …
  • Space Exploration Technologies Corp:戦略・SWOT・企業財務分析
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Regen BioPharma Inc (RGBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆